Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors (original) (raw)
Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts*1
Michel Brazier
Biochemical and Biophysical Research Communications, 2004
View PDFchevron_right
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems
Nada Riva
Bone, 2014
View PDFchevron_right
Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis
A. Sourla
Urology, 1998
View PDFchevron_right
Ability of breast cancer cell lines to stimulate bone resorbing activity of mature osteoclasts correlates with an anti-apoptotic effect mediated by macrophage colony stimulating factor
Michel Brazier
Apoptosis, 2006
View PDFchevron_right
Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment
Lucio Gnessi
Endocrine Related Cancer, 2007
View PDFchevron_right
Cytotoxicity in MCF-7 and MDA-MB-231 Breast Cancer Cells, without Harming MCF-10A Healthy Cells
Waheed ahmad baig
View PDFchevron_right
Synergistic antiproliferative effect of imatinib and adriamycin in PDGF receptor-expressing osteosarcoma cells
Nobuyuki Onishi
Cancer Science, 2015
View PDFchevron_right
Chemosensitizing Effect of Tamoxifen and ICI 182,780 on Parental and Adriamycin-resistant MCF-7 Human Breast Cancer Cells
Andrea Fattorossi
Annals of the New York Academy of Sciences, 1996
View PDFchevron_right
A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts
Ingunn Holen
Journal of Bone Oncology, 2012
View PDFchevron_right
Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions
Kim Mansky
PLOS ONE, 2017
View PDFchevron_right
Cell Death of MCF-7 Human Breast Cancer Cells Induced by EGFR Activation in the Absence of Other Growth Factors
Ruben Humberto Gomez Garcia
Cell Cycle, 2006
View PDFchevron_right
Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells
julie buckley
Cancer research, 1994
View PDFchevron_right
IN-VIVO EFFECT OF THE COMBINATION OF TNF AND ADRIAMYCIN AGAINST A HUMAN BREAST CELL-LINE EXPRESSING THE MDR-PHENOTYPE
Abdelmajid Zyad
International Journal of Oncology, 1995
View PDFchevron_right
Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis
Michael Andreeff
Journal of Cellular Physiology, 2004
View PDFchevron_right
Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment
Mitsuru Futakuchi
International journal of molecular sciences, 2018
View PDFchevron_right
Epidermal growth factor, phorbol esters, and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin
Zvi Malik
In Vitro Cellular & Developmental Biology - Animal, 1994
View PDFchevron_right
Apoptosis in Response to Anti-estrogens in MCF-7 Human Mammary Adenocarcinoma Cells
Jozo Delic
McGill Journal of Medicine, 2020
View PDFchevron_right
Inhibition of bone resorption and growth of breast cancer in the bone microenvironment
Jeroen Buijs
Bone, 2009
View PDFchevron_right
The Effect of Canertinib on Sensitivity of Cytotoxic Drugs in Tamoxifen-Resistant Breast Cancer Cells In Vitro
Mohammed Abdel-GAbbar
2018
View PDFchevron_right
Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
norma Alejandra chasseing
Cancer Cell International, 2012
View PDFchevron_right
In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line
Sumari Marais
The Journal of Steroid Biochemistry and Molecular Biology, 2010
View PDFchevron_right
Effects of insulin-like growth factor binding proteins in bone—a matter of cell and site
C. Rutherford
Archives Of Physiology And Biochemistry, 2007
View PDFchevron_right
Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
Thomas Lennard
The Women's Oncology Review, 2005
View PDFchevron_right
Osteoprotegerin Overexpression by Breast Cancer Cells Enhances Orthotopic and Osseous Tumor Growth and Contrasts with That Delivered Therapeutically
Jane Fisher
Cancer Research, 2006
View PDFchevron_right
Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
Eing-mei Tsai
International Journal of Oncology, 2014
View PDFchevron_right
Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation
Robert Mach
Cancer discovery, 2013
View PDFchevron_right
SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model
Paul Keast
Clinical & Experimental Metastasis, 2000
View PDFchevron_right
Differential Gene Expression of TGF-β Family Members and Osteopontin in Breast Tumor Tissue: Analysis by Real-Time Quantitative PCR
Patrick Roche
Breast Cancer Research and Treatment, 2002
View PDFchevron_right
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
Philippe Clézardin
JNCI Journal of the National Cancer Institute, 2012
View PDFchevron_right
Therapeutic targets for bone metastases in breast cancer
Philippe Clézardin
Breast Cancer Research, 2011
View PDFchevron_right